{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:18:27Z","timestamp":1793114307094,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007241","name":"Universit\u00e9 Paris-Saclay","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ebiom.2020.103129","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T23:29:22Z","timestamp":1606346962000},"page":"103129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Persistence of monocyte activation under treatment in people followed since acute HIV-1 infection relative to participants at high or low risk of HIV infection"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0154-9786","authenticated-orcid":false,"given":"Sophie","family":"Novelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"L\u00e9curoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Goujard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Reynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Villemant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Essat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Avettand-Feno\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2020.103129_bib0001","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1741-7015-11-251","article-title":"Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?","volume":"11","author":"Sabin","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.ebiom.2020.103129_bib0002","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/COH.0000000000000118","article-title":"Impact of antiretroviral therapy (ART) timing on chronic immune activation\/inflammation and end-organ damage","volume":"10","author":"Rajasuriar","year":"2015","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.ebiom.2020.103129_bib0003","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/cid\/ciw683","article-title":"Persistent, albeit reduced, chronic inflammation in persons starting antiretroviral therapy in acute HIV infection","volume":"64","author":"Sereti","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2020.103129_bib0004","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/QAI.0b013e318285cd33","article-title":"Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-Cell activation","volume":"62","author":"Vinikoor","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ebiom.2020.103129_bib0005","doi-asserted-by":"crossref","first-page":"e33948","DOI":"10.1371\/journal.pone.0033948","article-title":"Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection","volume":"7","author":"Ananworanich","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2020.103129_bib0006","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/infdis\/jiw275","article-title":"Immunologic biomarkers, morbidity, and mortality in treated HIV infection","volume":"214","author":"Hunt","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2020.103129_bib0007","first-page":"1","article-title":"Changes in levels of inflammation following antiretroviral treatment during early HIV infection in ACTG A5217","author":"Macatangay","year":"2017","journal-title":"Ournal Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ebiom.2020.103129_bib0008","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1093\/infdis\/jiz030","article-title":"Very early initiation of antiretroviral therapy during acute HIV infection is associated with normalized levels of immune activation markers in cerebrospinal fluid but not in plasma","volume":"220","author":"Hellmuth","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2020.103129_bib0009","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2020.103129_bib0010","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx108","article-title":"High cellular monocyte activation in people living with human immunodeficiency virus on combination antiretroviral therapy and lifestyle-matched controls is associated with greater inflammation in cerebrospinal fluid","volume":"4","author":"Booiman","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ebiom.2020.103129_bib0011","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/QAD.0000000000000545","article-title":"The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation","volume":"29","author":"Wada","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2020.103129_bib0012","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/infdis\/jiy244","article-title":"Increased systemic inflammation and gut permeability among women with treated HIV infection in rural Uganda","volume":"218","author":"Siedner","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2020.103129_bib0013","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/infdis\/jit508","article-title":"Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women","volume":"208","author":"Fitch","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2020.103129_bib0014","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/cid\/cix1068","article-title":"Long-term therapeutic impact of the timing of antiretroviral therapy in patients diagnosed with primary human immunodeficiency virus type 1 infection","volume":"66","author":"Novelli","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2020.103129_bib0015","doi-asserted-by":"crossref","first-page":"e71473","DOI":"10.1371\/journal.pone.0071473","article-title":"Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts","volume":"8","author":"Krastinova","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2020.103129_bib0016","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand preexposure prophylaxis in men at high risk for HIV-1 infection","volume":"373","author":"Molina","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2020.103129_bib0017","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/QAI.0000000000001807","article-title":"Social and Behavioral Consequences of participation in HIV preventive vaccine trials in the ANRS COHVAC cohort","volume":"79","author":"Durier","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ebiom.2020.103129_bib0018","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/JLB.3A0717-294RR","article-title":"Soluble CD14, CD163, and CD27 biomarkers distinguish ART-suppressed youth living with HIV from healthy controls","volume":"103","author":"Williams","year":"2018","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ebiom.2020.103129_bib0019","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jmv.21390","article-title":"LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01)","volume":"81","author":"Avettand-F\u00e8no\u00ebl","year":"2009","journal-title":"J Med Virol"},{"key":"10.1016\/j.ebiom.2020.103129_bib0020","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.immuni.2012.09.005","article-title":"HIV and HLA Class I: an evolving relationship","volume":"37","author":"Goulder","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2020.103129_bib0021","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.3389\/fimmu.2019.01965","article-title":"Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy","volume":"10","author":"Babu","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2020.103129_bib0022","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa099","article-title":"Partial normalization of biomarkers of inflammation and immune activation among virally suppressed men with HIV infection and high ART adherence","volume":"7","author":"Castillo-Mancilla","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ebiom.2020.103129_bib0023","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1128\/iai.64.5.1762-1769.1996","article-title":"Human monocyte CD14 is upregulated by lipopolysaccharide","volume":"64","author":"Landmann","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.ebiom.2020.103129_bib0024","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/cid\/ciw697","article-title":"Very early ART and persistent inflammation in treated HIV","volume":"64","author":"Hunt","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2020.103129_bib0025","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/QAI.0000000000001910","article-title":"Brief report: gut structural damage: an ongoing process in chronically untreated HIV infection","volume":"80","author":"El Kamari","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ebiom.2020.103129_bib0026","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2020.103129_bib0027","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/infdis\/jiu238","article-title":"Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection","volume":"210","author":"Hunt","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2020.103129_bib0028","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/cid\/ciw409","article-title":"Inflammatory biomarkers and mortality risk among HIV-suppressed men: a multisite prospective cohort study","volume":"63","author":"Wada","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2020.103129_bib0029","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/infdis\/jiu254","article-title":"Soluble markers of inflammation and coagulation but not T-Cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment","volume":"210","author":"Tenorio","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2020.103129_bib0030","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/infdis\/jir520","article-title":"Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients","volume":"204","author":"Burdo","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2020.103129_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006285","article-title":"Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation","volume":"13","author":"Gandhi","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2020.103129_bib0032","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijid.2016.10.004","article-title":"HIV and aging","volume":"53","author":"Wing","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ebiom.2020.103129_bib0033","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/COH.0b013e328335c2f6","article-title":"Th17 cytokines in mucosal immunity and inflammation","volume":"5","author":"Guglani","year":"2010","journal-title":"Curr Opin HIV AIDS"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420305053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420305053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:00:37Z","timestamp":1762455637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420305053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":33,"alternative-id":["S2352396420305053"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.103129","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistence of monocyte activation under treatment in people followed since acute HIV-1 infection relative to participants at high or low risk of HIV infection","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.103129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103129"}}